Citation Impact
Citing Papers
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
2010 StandoutScience
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Genomic and Proteomic Analysis Reveals a Threshold Level of MYC Required for Tumor Maintenance
2008
CRISPR/Cas9 in Genome Editing and Beyond
2016
High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding
2017 StandoutNobel
Machine learning predicts new anti-CRISPR proteins
2020 StandoutNobel
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients
2008
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors
2005
Precision cancer mouse models through genome editing with CRISPR-Cas9
2015
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Triple-Negative Breast Cancer
2010 Standout
Hallmarks of 'BRCAness' in sporadic cancers
2004
Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference
2015
MYC on the Path to Cancer
2012 Standout
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
2016 StandoutNature
Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines
2008
Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion
2018
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
2012
Expanding the Biologist’s Toolkit with CRISPR-Cas9
2015 StandoutNobel
C-Phycocyanin: A Potent Peroxyl Radical Scavenger in Vivo and in Vitro
2000 Standout
Genome-Editing Technologies: Principles and Applications
2016
RNA-based recognition and targeting: sowing the seeds of specificity
2017 StandoutNobel
Lung Cancer
2008 Standout
Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
2008 Standout
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
2005 StandoutNature
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
2014 Nature
Ubiquitin ligases: cell-cycle control and cancer
2006
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
2017 StandoutNature
Iterative In Situ Click Chemistry Creates Antibody‐like Protein‐Capture Agents
2009 StandoutNobel
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
2017 StandoutNatureNobel
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Disruption of Fnip1 Reveals a Metabolic Checkpoint Controlling B Lymphocyte Development
2012 StandoutNobel
The LKB1–AMPK pathway: metabolism and growth control in tumour suppression
2009
Cyclin D as a therapeutic target in cancer
2011
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Conformational control of DNA target cleavage by CRISPR–Cas9
2015 StandoutNatureNobel
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
A thermostable Cas9 with increased lifetime in human plasma
2017 StandoutNobel
The next generation of CRISPR–Cas technologies and applications
2019
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
2016 StandoutNobel
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
2017 StandoutNobel
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications
2017 StandoutNobel
Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9
2016 StandoutNobel
CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons
2017
Genome-editing revolution: My whirlwind year with CRISPR
2015 StandoutNatureNobel
Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21
2015 StandoutNobel
A Peptoid “Antibody Surrogate” That Antagonizes VEGF Receptor 2 Activity
2008
A prudent path forward for genomic engineering and germline gene modification
2015 StandoutScienceNobel
A Cas9–guide RNA complex preorganized for target DNA recognition
2015 StandoutScienceNobel
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 Standout
CRISPR-Cas9–guided oncogenic chromosomal translocations with conditional fusion protein expression in human mesenchymal cells
2017
Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas
2006
Dynamics of CRISPR-Cas9 genome interrogation in living cells
2015 StandoutScienceNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
2017 StandoutNobel
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
Basal-Like Breast Cancer: A Critical Review
2008
Genomic Engineering and the Future of Medicine
2015 StandoutNobel
Rational design of a split-Cas9 enzyme complex
2015 StandoutNobel
Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
2020 StandoutNobel
Engineering of temperature- and light-switchable Cas9 variants
2013 StandoutNobel
Autophagy and Metabolism
2010 StandoutScience
Target specificity of the CRISPR‐Cas9 system
2014
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Works of Sandra Rodríguez being referenced
Cyclin E gene ( CCNE ) amplification and hCDC4 mutations in endometrial carcinoma
2003
Development of a Real-Time Reverse Transcription Polymerase Chain Reaction Assay for c-myc Expression That Allows the Identification of a Subset of c-myc+ Diffuse Large B-Cell Lymphoma
2003
Cyclin D1 gene (CCND1) mutations in endometrial cancer
2003
Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations
2004
Molecular alterations associated with cyclin d1 overexpression in endometrial cancer
2004
Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system
2014
Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
2003
Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques
2003
ANTI-INFLAMMATORY ACTIVITY OF PHYCOCYANIN EXTRACT IN ACETIC ACID-INDUCED COLITIS IN RATS
1999